Elan's controlled-release OTCs
Executive Summary
Irish firm announces availability of following sustained-release OTC products for licensing -- Asprilan 12-hour aspirin tablets; Parelan 8-12 hour acetaminophen suspension; Elangesic twice-daily ibuprofen tablets; Elan-K potassium chloride suspension and tablets; "a range" of 12 and 24-hour cough/cold tablets containing a variety of ingredients singly and in combination; and Elan-PPA, a once-a-day appetite suppressant.